Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-18 5:00 pm Purchase | 2026-06-17 | 13G | BIODESIX INC BDSX | Soleus Capital Master Fund, L.P. | 525,241 5.100% | 108,642 (+26.08%) | Filing History |
| 2026-05-27 5:00 pm Purchase | 2026-05-26 | 13G | PALISADE BIO INC COM P PALI | Soleus Capital Master Fund, L.P. | 9,353,687 5.400% | 9,353,687 (New Position) | Filing History |
| 2026-05-27 5:00 pm Purchase | 2026-05-26 | 13G | INSPIRE MED SYS INC INSP | Soleus Capital Master Fund, L.P. | 1,470,748 5.100% | 1,470,748 (New Position) | Filing History |
| 2026-05-08 5:01 pm Purchase | 2026-03-31 | 13G | NOVOCURE LTD NVCR | Soleus Capital Master Fund, L.P. | 10,492,391 9.100% | 1,961,726 (+23.00%) | Filing History |
| 2026-05-08 5:01 pm Sale | 2026-03-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | Soleus Capital Master Fund, L.P. | 276,312 1.000% | -1,218,108 (-81.51%) | Filing History |
| 2026-05-08 5:01 pm Purchase | 2026-03-31 | 13G | GERON CORP GERN | Soleus Capital Master Fund, L.P. | 41,508,659 6.500% | 8,500,000 (+25.75%) | Filing History |
| 2026-05-08 5:00 pm Purchase | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Soleus Capital Master Fund, L.P. | 6,963,141 7.600% | 2,186,743 (+45.78%) | Filing History |
| 2026-05-08 5:00 pm Sale | 2026-03-31 | 13G | BIODESIX INC BDSX | Soleus Capital Master Fund, L.P. | 416,599 4.100% | -83,401 (-16.68%) | Filing History |
| 2026-05-07 5:01 pm Purchase | 2026-05-06 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund, L.P. | 968,108 5.200% | 309,963 (+47.10%) | Filing History |
| 2026-04-01 7:50 pm Purchase | 2026-03-31 | 13G | VERICEL CORPORATION VCEL | Soleus Capital Master Fund, L.P. | 2,549,079 5.000% | 2,549,079 (New Position) | Filing History |
| 2026-03-24 4:45 pm Purchase | 2026-03-23 | 13G | CERUS CORP CERS | Soleus Capital Master Fund, L.P. | 9,828,700 5.100% | 9,828,700 (New Position) | Filing History |
| 2026-03-09 5:00 pm Purchase | 2026-03-06 | 13G | PULMONX CORP LUNG | Soleus Capital Master Fund, L.P. | 2,665,100 6.500% | 2,665,100 (New Position) | Filing History |
| 2026-03-03 4:30 pm Purchase | 2026-02-25 | 13G | GERON CORP GERN | Soleus Capital Master Fund, L.P. | 33,008,659 5.200% | 33,008,659 (New Position) | Filing History |
| 2026-02-19 4:30 pm Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Soleus Capital Master Fund, L.P. | 679,200 5.500% | 679,200 (New Position) | Filing History |
| 2026-02-12 5:02 pm Purchase | 2025-12-31 | 13G | C4 THERAPEUTICS INC CCCC | Soleus Capital Master Fund, L.P. | 10,361,860 9.990% | 3,757,864 (+56.90%) | Filing History |
| 2026-02-12 5:01 pm Sale | 2025-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Soleus Capital Master Fund, L.P. | 212,710 0.200% | -7,929,790 (-97.39%) | Filing History |
| 2026-02-12 5:01 pm Sale | 2025-12-31 | 13G | ORGANOGENESIS HLDGS INC CLASS ORGO | Soleus Capital Master Fund, L.P. | 9,985,951 7.900% | -2,498,925 (-20.02%) | Filing History |
| 2026-02-12 5:01 pm Sale | 2025-12-31 | 13G | NOVOCURE LTD NVCR | Soleus Capital Master Fund, L.P. | 8,530,665 7.600% | -1,114,207 (-11.55%) | Filing History |
| 2026-02-03 4:41 pm Purchase | 2026-02-02 | 13G | CONTEXT THERAPEUTICS INC CNTX | Soleus Capital Master Fund, L.P. | 4,776,398 5.200% | 4,776,398 (New Position) | Filing History |
| 2026-01-13 4:31 pm Purchase | 2026-01-12 | 13G | BIODESIX INC BDSX | Soleus Capital Master Fund, L.P. | 500,000 6.300% | 500,000 (New Position) | Filing History |